tradingkey.logo

Fortrea Holdings Inc

FTRE

10.650USD

+0.340+3.30%
Fechamento 09/18, 16:00ETCotações atrasadas em 15 min
967.02MValor de mercado
PerdaP/L TTM

Fortrea Holdings Inc

10.650

+0.340+3.30%
Mais detalhes de Fortrea Holdings Inc Empresa
Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
Informações da empresa
Código da empresaFTRE
Nome da EmpresaFortrea Holdings Inc
Data de listagemJun 16, 2023
CEOMr. Anshul Thakrala
Número de funcionários15500
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 16
Endereço8 Moore Drive
CidadeDURHAM
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal27709
Telefone18774950816
Sitehttps://www.fortrea.com/
Código da empresaFTRE
Data de listagemJun 16, 2023
CEOMr. Anshul Thakrala
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+175.40%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Morais
Mr. Mark Morais
Chief Operating Officer and President - Clinical Services
Chief Operating Officer and President - Clinical Services
--
--
Ms. Erin L. Russell
Ms. Erin L. Russell
Independent Director
Independent Director
--
--
Ms. Hima B. Inguva
Ms. Hima B. Inguva
Investor Relations
Investor Relations
--
--
Mr. Anshul Thakrala
Mr. Anshul Thakrala
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+175.40%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2021
FY2020
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
North America
309.50M
47.52%
Europe
200.30M
30.75%
Other
141.50M
21.73%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sáb, 16 de ago
Atualizado em: sáb, 16 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
14.03%
The Vanguard Group, Inc.
9.37%
Goldman Sachs & Company, Inc.
8.53%
AQR Capital Management, LLC
7.18%
Corvex Management LP
4.97%
Outro
55.93%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
14.03%
The Vanguard Group, Inc.
9.37%
Goldman Sachs & Company, Inc.
8.53%
AQR Capital Management, LLC
7.18%
Corvex Management LP
4.97%
Outro
55.93%
Tipos de investidores
Investidores
Proporção
Investment Advisor
46.00%
Hedge Fund
24.41%
Investment Advisor/Hedge Fund
22.94%
Research Firm
13.87%
Bank and Trust
2.55%
Pension Fund
2.42%
Individual Investor
0.52%
Family Office
0.39%
Sovereign Wealth Fund
0.05%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
941
91.16M
100.39%
-22.39M
2025Q1
942
95.79M
105.84%
-17.15M
2024Q4
898
97.88M
109.12%
-17.67M
2024Q3
853
101.51M
113.29%
-12.93M
2024Q2
825
103.91M
116.10%
+693.93K
2024Q1
782
93.40M
104.47%
-524.01K
2023Q4
716
91.67M
103.23%
-7.08M
2023Q3
616
90.69M
102.13%
+51.44M
2023Q2
43
6.20M
7.00%
+6.20M
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
10.95M
12.1%
-180.41K
-1.62%
Mar 31, 2025
The Vanguard Group, Inc.
9.85M
10.88%
+12.67K
+0.13%
Mar 31, 2025
AQR Capital Management, LLC
1.10M
1.21%
+706.78K
+181.92%
Mar 31, 2025
Corvex Management LP
4.47M
4.94%
+994.00K
+28.56%
Mar 31, 2025
State Street Global Advisors (US)
3.26M
3.61%
-107.87K
-3.20%
Mar 31, 2025
Sessa Capital
4.69M
5.19%
-1.96M
-29.51%
Mar 31, 2025
Fidelity Management & Research Company LLC
4.05M
4.48%
-2.13M
-34.48%
Mar 31, 2025
Starboard Value LP
2.72M
3%
-2.55M
-48.44%
May 12, 2025
Geode Capital Management, L.L.C.
1.58M
1.75%
+87.80K
+5.88%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de set
Atualizado em: sáb, 6 de set
Nome
Proporção
Humankind US Stock ETF
0.14%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
0.06%
Vanguard US Value Factor ETF
0.04%
iShares Morningstar Small-Cap Value ETF
0.03%
WisdomTree US SmallCap Fund
0.02%
Proshares Ultra Russell 2000
0.02%
ProShares UltraPro Russell2000
0.02%
FlexShares Morningstar US Market Factor Tilt Index Fund
0.02%
Invesco Russell 1000 Equal Weight ETF
0%
Fidelity MSCI Health Care Index ETF
0%
Ver Mais
Humankind US Stock ETF
Proporção0.14%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
Proporção0.06%
Vanguard US Value Factor ETF
Proporção0.04%
iShares Morningstar Small-Cap Value ETF
Proporção0.03%
WisdomTree US SmallCap Fund
Proporção0.02%
Proshares Ultra Russell 2000
Proporção0.02%
ProShares UltraPro Russell2000
Proporção0.02%
FlexShares Morningstar US Market Factor Tilt Index Fund
Proporção0.02%
Invesco Russell 1000 Equal Weight ETF
Proporção0%
Fidelity MSCI Health Care Index ETF
Proporção0%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI